SCHEMBL8929753

SCHEMBL8929753

CC(C)OC(=O)c1cc(N=C=O)ccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 4/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
CA12 O43570 6/20 0.41
CA1 P00915 6/20 0.41
CA2 P00918 6/20 0.41
CA7 P43166 6/20 0.41
CA9 Q16790 6/20 0.41
CA14 Q9ULX7 6/20 0.41
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
TRPA1 O75762 1/20 0.37
CYP3A4 P08684 1/20 0.37
MAPT P10636 3/20 0.37
RXFP1 Q9HBX9 1/20 0.37
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
KDM4E B2RXH2 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9858564 0.89 MAPK1 (0.50) MAPK1TDP1ALDH1A1LMNAPOLB
SCHEMBL10917876 0.87 ALDH1A1 (0.45) MAPK1TDP1ALDH1A1LMNAPOLB
SCHEMBL9652526 0.84 TRPA1 (0.49) MAPK1TDP1ALDH1A1LMNAPOLB
SCHEMBL9756688 0.84 MAPK1 (0.45) MAPK1TDP1ALDH1A1LMNAPOLB
SCHEMBL25286184 0.81 CYP4F2 (0.43) MAPK1TDP1ALDH1A1LMNAPOLB
SCHEMBL25242327 0.81 CYP4F2 (0.43) MAPK1TDP1ALDH1A1LMNAPOLB
SCHEMBL10644838 0.80 CYP4F2 (0.59) MAPK1TDP1ALDH1A1CA12CA1
SCHEMBL30987212 0.79 CYP4F2 (0.41) MAPK1TDP1ALDH1A1LMNAPOLB
SCHEMBL7933673 0.78 MAPK1 (0.44) MAPK1TDP1ALDH1A1LMNAPOLB
SCHEMBL7826908 0.77 CYP4F2 (0.42) MAPK1TDP1ALDH1A1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5693827-A Treatment of HIV infections and compounds useful therein UNIROYAL CHEMICAL COMPANY, INC. 1997-12-02 US disclosed
EP-0497816-B1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD (CA) 1995-05-17 EP disclosed
US-5268389-A Containing a benzene ring UNIROYAL CHEMICAL COMPANY, INC. (US) 1993-12-07 US disclosed
EP-0497816-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. UNIROYAL CHEMICAL LTD (CA) 1992-08-12 EP disclosed
WO-1991005761-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) 1991-05-02 WO disclosed